Ryan Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RYAN LABS, and what generic and branded alternatives to RYAN LABS drugs are available?
RYAN LABS has four approved drugs.
Summary for Ryan Labs
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Ryan Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ryan Labs | RASAGILINE MESYLATE | rasagiline mesylate | TABLET;ORAL | 201942-002 | Nov 18, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ryan Labs | LETROZOLE | letrozole | TABLET;ORAL | 091191-001 | Jun 3, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ryan Labs | RASAGILINE MESYLATE | rasagiline mesylate | TABLET;ORAL | 201942-001 | Nov 18, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ryan Labs | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 202077-001 | Feb 11, 2013 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ryan Labs | VIGABATRIN | vigabatrin | TABLET;ORAL | 215519-001 | Apr 28, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
